LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 59.42 | 21.74 | 20 | 6125 | 0.0033 | -0.0102 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 59.42 | 21.74 | 4492 | 6125 | 0.7333 | 0.9252 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 62.39 | 21.74 | 415 | 6112 | 0.0679 | 0.4369 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 62.39 | 21.74 | 3929 | 6112 | 0.6428 | 0.8942 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 62.39 | 21.74 | 10 | 6112 | 0.0016 | -0.0910 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 62.39 | 21.74 | 4778 | 6112 | 0.7816 | 0.9403 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 64.36 | 21.74 | 494 | 6191 | 0.0798 | 0.4668 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 64.36 | 21.74 | 4186 | 6191 | 0.6761 | 0.9063 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 64.36 | 21.74 | 12 | 6191 | 0.0019 | -0.0703 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 64.36 | 21.74 | 5061 | 6191 | 0.8175 | 0.9512 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 66.33 | 21.74 | 576 | 6235 | 0.0924 | 0.4939 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 66.33 | 21.74 | 4452 | 6235 | 0.7140 | 0.9191 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 66.33 | 21.74 | 15 | 6235 | 0.0024 | -0.0444 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 66.33 | 21.74 | 5323 | 6235 | 0.8537 | 0.9616 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 68.30 | 21.74 | 645 | 6244 | 0.1033 | 0.5146 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 68.30 | 21.74 | 4634 | 6244 | 0.7421 | 0.9283 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 68.30 | 21.74 | 12 | 6244 | 0.0019 | -0.0702 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 68.30 | 21.74 | 5578 | 6244 | 0.8933 | 0.9725 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 70.27 | 21.74 | 651 | 6201 | 0.1050 | 0.5171 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 70.27 | 21.74 | 4830 | 6201 | 0.7788 | 0.9396 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 70.27 | 21.74 | 12 | 6201 | 0.0019 | -0.0703 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 70.27 | 21.74 | 5903 | 6201 | 0.9518 | 0.9879 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 72.24 | 21.74 | 708 | 6162 | 0.1149 | 0.5335 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 72.24 | 21.74 | 5054 | 6162 | 0.8202 | 0.9519 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 72.24 | 21.74 | 9 | 6162 | 0.0015 | -0.1026 | MN20160310_N01 | G15 |